GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read More

GSK announced Tuesday it will acquire Nuvalent, a cancer drug developer, for $10.6 billion. CEO Luke Miels, six months into…
Read MoreItaly's largest banking group, Intesa Sanpaolo, launched an unsolicited €30.6 billion ($35 billion) cash-and-share bid on Monday, June 8, to…
Read MoreEstée Lauder's merger talks with Puig, the owner of Jean Paul Gaultier, collapsed over price disagreements, CEO Stéphane de La…
Read More
Attorneys general from 10 states, including California, New York, Oregon, Nevada, Colorado, Connecticut, Massachusetts, Tennessee, and Pennsylvania, are reportedly exploring…
Read More
Spruce Biosciences (Nasdaq: SPRB) has announced a new corporate strategy centered on the acquisition of tralesinidase alfa enzyme replacement therapy…
Read MoreEstée Lauder's CEO Stephane de La Faverie confirmed Tuesday that merger talks with Spanish fragrance group Puig, owner of Jean…
Read More
Canada's oilpatch is expected to continue consolidating through mergers and acquisitions in 2026, though likely at a smaller scale than…
Read More
The Biden administration unveiled stricter merger review guidelines on Wednesday, with FTC Chair Lina Khan and DOJ antitrust chief Jonathan…
Read More
The Trump administration is pressing forward with antitrust action against major tech companies despite industry hopes for a lighter touch.…
Read More
European crypto asset manager CoinShares began trading on Nasdaq Wednesday under the ticker CSHR, following its merger with SPAC Vine…
Read More